SCHEMBL5680692

SCHEMBL5680692

O=S(=O)(Cl)c1ccccc1Cc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL2 P10415 1/20 0.45
BCL2L1 Q07817 1/20 0.45
NR1H2 P55055 1/20 0.44
HTR2A P28223 1/20 0.42
CALM1 P0DP23 1/20 0.42
ALDH1A1 P00352 2/20 0.41
HSD17B10 Q99714 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
CTRC Q99895 3/20 0.41
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
CA9 Q16790 2/20 0.38
MEN1 O00255 1/20 0.38
CYP3A4 P08684 1/20 0.38
HPGD P15428 1/20 0.38
ALOX15 P16050 1/20 0.38
KMT2A Q03164 1/20 0.38
HIF1A Q16665 1/20 0.38
CA12 O43570 1/20 0.38
CA14 Q9ULX7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22233464 0.83 BCL2 (0.48) BCL2BCL2L1NR1H2HTR2ACALM1
SCHEMBL5681255 0.82 NR1H2 (0.45) NR1H2ALDH1A1HSD17B10TDP1CA1
SCHEMBL9822747 0.80 MEN1 (0.56) BCL2BCL2L1NR1H2ALDH1A1HSD17B10
SCHEMBL30988956 0.80 CA2 (0.50) BCL2BCL2L1HTR2ACA1CA2
SCHEMBL5700547 0.80 BCL2 (0.45) BCL2BCL2L1NR1H2HTR2ACALM1
SCHEMBL13413605 0.80 BCL2 (0.45) BCL2BCL2L1NR1H2HTR2ACALM1
SCHEMBL407413 0.80 CA2 (0.50) BCL2BCL2L1HTR2ACA1CA2
SCHEMBL29740732 0.80 BCL2 (0.50) BCL2BCL2L1NR1H2HTR2ACALM1
SCHEMBL28375617 0.80 ELANE (0.47) BCL2BCL2L1NR1H2HTR2ACALM1
SCHEMBL7738158 0.80 BCL2 (0.50) BCL2BCL2L1NR1H2HTR2ACALM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115636802-A Resveratrol acryloyl piperazine benzene sulfonamide derivative and preparation and application thereof 合肥学院 2023-01-24 CN disclosed
CN-109020922-B Preparation method of cyclic sulfonamide compound 陕西师范大学 2022-01-04 CN disclosed
EP-2721006-A1 HETEROCYCLIC COMPOUNDS FOR TREATING HELMINTH INFECTIONS E. I. Du Pont de Nemours and Company (US) 2014-04-23 EP disclosed
WO-2012177668-A1 HETEROCYCLIC COMPOUNDS FOR TREATING HELMINTH INFECTIONS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2012-12-27 WO disclosed
EP-0932600-B1 SULFONAMIDE SUBSTITUTED ASPARTIC ACID INTERLEUKIN-1BETA CONVERTING ENZYME INHIBITORS WARNER LAMBERT CO (US) 2006-02-08 EP disclosed
US-6083981-A USEFUL FOR TREATMENT OF STROKE, INFLAMMATORY DISEASES, SEPTIC SHOCK, REPERFUSION INJURY, ALZHEIMER'S DISEASE, SHIGELLOSIS WARNER-LAMBERT COMPANY (US) 2000-07-04 US disclosed
US-6054487-A ADMINISTERING AN INTERLEUKIN-ONE BETA CONVERTING ENZYME SUFFICIENT TO INHIBIT PRODUCTION OF GAMMA-INTERFERON BASF AKTIENGESELLSCHAFT (DE) 2000-04-25 US disclosed